Total Payments
$1,221
2024 Payments
$60.35
Companies
15
Transactions
67
Medicare Patients
8,245
Medicare Billing
$723,132
Payment Breakdown by Category
Food & Beverage$1,221 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,221 | 67 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $285.20 | 7 | $0 (2018) |
| PFIZER INC. | $179.16 | 21 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $157.19 | 7 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $137.51 | 4 | $0 (2018) |
| ABBVIE INC. | $131.54 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $96.14 | 7 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $90.70 | 4 | $0 (2018) |
| Abbott Laboratories | $31.74 | 2 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $23.62 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $19.72 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60.35 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($22.10) |
| 2023 | $58.83 | 3 | Xeris Pharmaceuticals, Inc. ($23.62) |
| 2022 | $94.80 | 6 | ABBVIE INC. ($41.97) |
| 2021 | $93.76 | 6 | AbbVie Inc. ($48.48) |
| 2020 | $11.97 | 1 | PFIZER INC. ($11.97) |
| 2019 | $41.19 | 3 | Janssen Pharmaceuticals, Inc ($41.19) |
| 2018 | $231.23 | 10 | AstraZeneca Pharmaceuticals LP ($112.54) |
| 2017 | $628.54 | 35 | AstraZeneca Pharmaceuticals LP ($172.66) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Diabetes Care | ||||||
| 05/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.10 | General |
| 01/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Diabetes | ||||||
| 02/15/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: VACCINES | ||||||
| 11/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/06/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Diabetes Care | ||||||
| 04/20/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: VACCINES | ||||||
| 01/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: PRIMARY CARE | ||||||
| 09/08/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: PSYCHIATRY | ||||||
| 03/30/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS, REYVOW | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: WOMENS HEALTH | ||||||
| 07/28/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.05 | General |
| Category: Cardiovascular | ||||||
| 08/30/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,844 | 3,282 | $382,583 | $200,276 |
| 2022 | 39 | 2,323 | 3,669 | $368,413 | $187,929 |
| 2021 | 36 | 2,242 | 3,879 | $335,021 | $179,623 |
| 2020 | 29 | 1,836 | 3,520 | $350,491 | $155,305 |
Total Patients
8,245
Total Services
14,350
Medicare Billing
$723,132
Procedure Codes
133
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 259 | 755 | $116,195 | $59,445 | 51.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 122 | 811 | $69,746 | $36,530 | 52.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 179 | 179 | $32,041 | $21,727 | 67.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 209 | 211 | $33,760 | $15,523 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 174 | $18,094 | $10,029 | 55.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 81 | 217 | $21,027 | $7,734 | 36.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $10,392 | $6,789 | 65.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $12,443 | $4,271 | 34.3% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 173 | 173 | $6,462 | $4,214 | 65.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 19 | $6,306 | $3,951 | 62.6% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 36 | 36 | $5,100 | $3,295 | 64.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 44 | 44 | $4,270 | $3,162 | 74.0% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 19 | 19 | $4,158 | $2,717 | 65.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 149 | 149 | $3,844 | $2,550 | 66.3% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 39 | 44 | $5,396 | $2,496 | 46.2% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 36 | 36 | $4,545 | $2,359 | 51.9% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 54 | 54 | $6,588 | $2,250 | 34.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $3,738 | $2,188 | 58.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $2,700 | $1,756 | 65.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 48 | $1,734 | $1,365 | 78.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 11 | 11 | $3,252 | $885.12 | 27.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 24 | $2,184 | $862.18 | 39.5% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 30 | 30 | $1,638 | $806.70 | 49.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 19 | 22 | $1,166 | $761.64 | 65.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 19 | 19 | $1,140 | $720.67 | 63.2% |
About Dr. Hak Seo, MD
Dr. Hak Seo, MD is a Internal Medicine healthcare provider based in Dayton, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1043471238.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hak Seo, MD has received a total of $1,221 in payments from pharmaceutical and medical device companies, with $60.35 received in 2024. These payments were reported across 67 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,221).
As a Medicare-enrolled provider, Seo has provided services to 8,245 Medicare beneficiaries, totaling 14,350 services with total Medicare billing of $723,132. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Dayton, TN
- Active Since 06/19/2008
- Last Updated 06/21/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043471238
Products in Payments
- BEVESPI AEROSPHERE (Drug) $229.06
- JARDIANCE (Drug) $135.09
- TOUJEO (Drug) $121.16
- VRAYLAR (Drug) $111.20
- CHANTIX (Drug) $92.56
- BELSOMRA (Drug) $75.98
- XARELTO (Drug) $70.52
- FARXIGA (Drug) $56.14
- ELIQUIS (Drug) $30.24
- INVOKANA (Drug) $25.62
- GVOKE HYPOPEN (Drug) $23.62
- LYRICA (Drug) $22.55
- UBRELVY (Drug) $20.34
- ENTRESTO (Drug) $19.72
- PREVNAR 20 (Biological) $19.28
- PREMARIN (Drug) $18.15
- FREESTYLE LIBRE 3 (Device) $17.91
- SOLIQUA (Drug) $16.35
- JANUVIA (Drug) $14.72
- INJECTAFER (Drug) $14.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dayton
Miguel Parilo, Md, MD
Internal Medicine — Payments: $165,368
Internal Medicine $165,368
Dr. Isaac Humphrey, M.d, M.D
Internal Medicine — Payments: $150,806
Internal Medicine $150,806
Kirshan Lal, Md, MD
Internal Medicine — Payments: $82,779
Internal Medicine $82,779
Dr. Daniel Pearson, M.d, M.D
Internal Medicine — Payments: $61,416
Internal Medicine $61,416
Dr. Mohamed Elmouelhi, Md, Phd, MD, PHD
Internal Medicine — Payments: $44,032
Internal Medicine $44,032
Mamle Anim, Md, MD
Internal Medicine — Payments: $35,552
Internal Medicine $35,552